Optimisation of intermittent pneumatic compression in patients with oedema of the legs of different etiologies - IPC+ trial

Bauerfeind AG - Phlebology Business Development & Medical Affairs0 个研究点目标入组 18 人开始时间: 2022年8月4日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Oedema of the legs: primary and secondary lymphoedema, phleboedema, lipoedema.
•Willingness and ability of the patient to apply intermittent pneumatic compression and to wear multi-layer compression bandages, and to follow the instructions of the doctor and the staff
•Age between = 18 years
•Presentation of the written declaration of consent to participate in the observational study after detailed information about the nature, significance, risks and scope of the observational study as well as about the expected desired and undesired effects of the treatment in the context of the observational study.
•Sufficient written and spoken German language skills

•Acute deep venous thrombosis and acute thrombophlebitis
•Peripheral arterial occlusive disease stage III and IV according to Fontaine
•Decompensated heart failure and severe, non-adjustable arterial hypertension (diastolic > 100 mmHg)
•Acute tissue trauma, acute erysipelas (with systemic signs such as fever, reduced general condition, signs of sepsis)

发起方

Bauerfeind AG - Phlebology Business Development & Medical Affairs